Article info
PDFBasic Science
Eradication of Growth of HER2-Positive Ovarian Cancer With Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate in Mouse Xenograft Model
- Address correspondence and reprint requests to Lantu Gou and Jinliang Yang, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, People’s South Rd 17, Chengdu 610041, China. E-mail: goulantu{at}gmail.com; jlyang01{at}163.com.
Citation
Eradication of Growth of HER2-Positive Ovarian Cancer With Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate in Mouse Xenograft Model
Publication history
- Received November 22, 2014
- Accepted April 29, 2014
- First published September 1, 2014.
Online issue publication
June 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2014 by IGCS and ESGO